infection, the risk being nearly 50 times higher than in the normal population [1] . Diagnosis and treatment Background. In this study, renal transplant recipients of tuberculosis are more complicated in transplanted with tuberculosis of different organs, were retrospectpatients. The reasons include atypical presentation and ively analysed with respect to prevalence, outcome and interactions between antituberculous and immunodrug toxicity.
after the first year of transplantation. The most Patients and methods common form was pleuro/pulmonary tuberculosis (54%), and other localizations included jejunum, liver, Patients bone, and urogenital tract. Results. Sixteen of the 22 patients responded favourably Between 1983 and 1996 , 520 renal allograft recipients (403 to the treatment and maintain excellent allograft func-male, 117 female; 209 cadaveric, 213 living-related donor, 98 tion, whereas six patients (27.2%) died. Toxic hepatitis living-unrelated donor origin) were followed in our transplantation out-patient clinic. In 22 patients tuberculosis was was seen in four (18%) patients, and one case was diagnosed. They are the subjects of this retrospective analysis. complicated with acute hepatocellular failure due to Information on demographic characteristics, diagnostic isoniazide (INH ). However, of the 23 patients at risk of methods, immunosupressive and antituberculous therapy tuberculosis who had had INH prophylaxis for 1 year, protocols, response to and complications of the therapies, neither tuberculosis, nor hepatotoxicity was observed. and the outcomes of patients and allografts was obtained by
Conclusion.
Tuberculosis is a common infection of renal reviewing patients' charts. transplant recipients in developing countries. The peak incidence is after the first year of transplantation and Immunosuppressive protocol mortality is considerable. Hepatoxicity is a considerable risk of treatment, possibly as a result of additive toxic All patients who were transplanted before 1988 had been taking azathioprine (AZA) 1 mg/kg/day, plus prednisolone effects of immunosupressive drugs.
Introduction
weekly within the first month of antituberculous therapy and once monthly thereafter, using a fluorescence polarization immunoassay (Tdx).
Tuberculosis is frequent in developing countries. Because of drug-induced immunosupression, renal III Diagnosis of tuberculosis transplant recipients are more prone to develop this 
Protocol of antituberculous therapy
All of the patients had been treated with both INH and rifampicin, along with pyrazinamid and/or ethambutol for the first 2 months. Therapy was continued at least for 12 months. Liver function tests were monitored weekly in first month. Increased serum transaminase (>4-fold over the baseline) was taken as evidence of toxic hepatitis, INH was witheld until serum transaminase had returned to normal.
Protocol of antituberculosis chemoprophylaxis
Antituberculous prophylaxis was applied to patients who had a past history of tuberculosis, and/or tuberculosis sequelae on chest X-ray. INH was given at a dose of 300 mg/day for 1 year.
Results

Demography
Tuberculosis was diagnosed in 22 of 520 renal trans- culosis appeared in another patient, with cavitary (AZA+PRD; three patients) therapy protocols. The pulmonary tuberculosis 1 year after stopping antitubertime interval between transplantation and diagnosis of culous drugs. tuberculosis was 44.4±33.5 months (range 3-111). In 18 (82%) of the patients, tuberculosis was detected after the first year of transplantation. Mean serum Clinical presentation creatinine was 2.0±1.6 mg/dl (range 0.9 and 8.0) and Six of the patients presented with fever of unknown only in three patients' serum creatinine was >2 mg/dl, origin and were found to have miliary [1] , isolated at the time of diagnosis. Four patients had a history liver [1] or pulmonary [3] tuberculosis. Despite extensof acute rejection and had taken high dose of steroids ive investigations, the aetiology of the fever remained to reverse rejection. obscure in one patient. Because he responded favourably to antituberculous therapy, the diagnosis of tuberLocalization of tuberculosis culosis was accepted. One patient with jejunal The most common site was lungs (eight patients; 36%), involvement was admitted with intestinal perforation. or pleura (four patients; 18%); i.e. pleuropulmonary Other patients presented with low grade fever, constiinvolvement accounted for more than half of the cases. tutional symptoms and symptoms related to organ Isolated extrapulmonary tuberculosis was diagnosed involvement. in seven (31%) of the patients: granulomatous hepatitis with caseous necrosis in two patients (11%), and in Results of diagnostic interventions one patient each: intestinal tuberculosis (see Figure 1) , tuberculosis osteomyelitis, urogenital, pericardial and Fifteen patients had pathological findings on chest X-ray (soft opacities/infiltration in six, pleural effusion meningial tuberculosis. Disseminated tuberculosis was seen in three patients, two of whom had miliary in four, cavities in three, miliary shadows in two).
Mycobacterium tuberculosis was isolated in four shadows on chest X-ray.
One of the patients with cavitary pulmonary tubercu-patients; from sputum [3] and urine specimens [1] . Caseating granuloma was detected in liver biopsies of losis developed meningial tuberculosis 3 months after
In eight of the patients with (4.2%) is moderately high, probably because of the relatively high frequency of tuberculosis in Turkey. tuberculosis, the diagnosis was confirmed by histopathological examination (pleura: four, jejunum: one,
The most common presentation is pulmonary/ pleural involvement often followed by dissemination. liver: two and bone: one). The Mantoux skin test was found negative in all nine patients in whom it was In the literature, these two forms of involvement account for more than 3/4 of the patients [1, 3, 4] . performed.
Rubin [5] emphasized that the frequency of extrapulmonary tuberculosis is higher in organ transplant Results of the treatment and the outcome recipients as compared to patients who are not taking Sixteen (72%) of the 22 patients responded favourably immunosupressive drugs. Indeed, many cases of bone, to the treatment and improved with excellent allograft soft tissue (skin or muscular involvement), small intestfunction, whereas six (27%) deceased. Four of the ine, vulva, and larynx tuberculosis have been reported patients died as a result of disseminated tuberculosis, [3, [6] [7] [8] [9] . The proportion of isolated extrapulmonary despite cessation of immunosuppressive therapy. One tuberculosis was 7/22 patients (31%) in our series in patient died due to liver failure, which was probably agreement with the previous reports [1, 3, 4, 10] . the result of INH-mediated chronic active hepatitis, Because of the atypical clinical and laboratory findand another patient died because of jejunal perforation ings, diagnosis of tuberculosis is more complicated in and sepsis.
immunosuppressed patients. This may cause a delay Kaposi's sarcoma developed in two patients with in diagnosis and treatment. In our series, six of the miliary tuberculosis 2 and 23 months after diagnosis patients (30%) presented with fever of unknown origin. of tuberculosis. Regarding allograft function, two of In developing countries, tuberculosis is apparently a the patients had returned to haemodialysis within the common cause of fever of unknown origin, especially following 6 months of therapy, both of whom had after the first year of transplantation. Another major serum creatinine >2 mg/dl at the time of diagnosis of problem in these patients is the hepatotoxicity of tuberculosis.
antituberculous drugs, especially of INH. It seems to be safe to use of INH alone. Among 1033 patients Side-effects of treatment who were on INH prophylaxis, it was reported that only three patients developed toxic hepatitis attributed Toxic hepatitis was seen in four (18%) patients. After to INH [11] . Recently, Antony et al. [12] reported withdrawal of INH, serum transaminase levels rapidly that none of the 83 patients who had received INH returned to normal in the first week and excluding the prophylaxis had toxic hepatitis or required discontinuabove mentioned patient who progressed to chronic ation of the drug. They proposed that the risk of INH active hepatitis and liver failure, INH was readminis-hepatotoxicity is low and not different from normal tered in all cases. Following reinstitution, no abnormal-individuals. It has been reported that administration ity in serum transaminase was observed. Because of of rifampicin together with INH increases the risk of drug interaction between rifampicin and CycA, the hepatotoxicity up to 8% in nontransplanted patients. dose of the latter was increased up to 4-fold in 10 of A fatal course was reported in 4.6% of the patients the patients in order to achieve target serum concentra-with toxic hepatitis [13] . Although this possibility has tions. In one of the patients, 2 weeks after start of not been definitely proven, hepatotoxicity of AZA and antituberculosus therapy, acute adrenal insufficiency CycA may contribute to this complication. In our developed, and symptoms improved when the daily series, we noted a >4-fold increase of serum transaminsteroid dose was increased.
ase levels in four patients (18%), i.e. more frequently than in nontransplanted patients [13] , in agreement Results of chemoprophylaxis with the findings of Sakhuja et al. [10] . By increasing hepatic microsomal cytochrom P-450 Twenty-three patients were at risk of tuberculosis (see enzyme activity, rifampicine decreases CycA levels above) and received prophylaxis with 300 mg INH/day [14] . In our series, the dose had to be increased by for 12 months. Tuberculosis and toxic hepatitis 50-400% to achieve pretreatment serum concentradeveloped in none of the patients. One patient with a tions. By close readjustment of the dosage and close history of tuberculous osteomyelitis had received a monitoring, these levels had reached a steady state living non-related donor allograft in India; he did not nearly 4 weeks after starting of rifampicine. Rifampicin receive INH prophylaxis and tuberculous osteomyelitis may also increase the clearance of prednisolon and by recurred in the same site 16 months after renal decreasing net immunosupressive state, may result in transplantation.
an increased risk of acute allograft rejection. We did not see any rejection episode during antituberculous Discussion therapy, but acute adrenal insufficiency was noted in one patient. After this experience, it became our routine practice to increase daily prednisolone dose by 50% In developed Western countries, the prevalence of tuberculosis in renal transplant recipients ranges from just after starting rifampicin. 
